Skip to content
Study details
Enrolling now

Vibrotactile Coordinated Reset Trial

Synergic Medical Technologies, Inc.
NCT IDNCT05881460ClinicalTrials.gov data as of Apr 2026
Target enrollment

30

Study length

about 2.6 years

Ages

45–85

Locations

1 site in OR

What this study is about

This trial is testing a device called the Vibrotactile (VT) Touch device to help people with Parkinson's disease. The treatment, vibrotactile coordinated reset, may delay the need for more medication and offer flexibility compared to deep brain stimulation.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Use Active vibrotactile coordinated reset
  • 2.Use Sham vibrotactile coordinated reset

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Change in Movement Disorders Society's Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part 3

Secondary: Quality of life improvements

Body systems

Neurology